The Attention Deficit Hyperactivity Disorder (ADHD) Observational Research in Europe (ADORE) project aims to describe the relationship between prescribed treatment regimen and quality of life in ADHD patients across Europe over a 2-year period. As an adjunct to the ADORE study, a survey was conducted to assess the availability and range of ADHD treatment services in the UK. A questionnaire was developed to assess service provision at 20 UK ADORE sites. These data give information regarding the assessment process (i.e. the formal psychological instrumentation used), whether information is requested from schools, and what other medical and allied health care specialities are frequently involved in the diagnosis. Results of the survey provide an important insight into the ADHD-related services provided by ADORE centres, as well as highlighting the availability and limitations of such services.
Addiss. (2004). ADHD: Paying enough attention? A research report investigating ADHD in the UK. Downloaded January, 10, 2006, from http://www.addiss.co.uk/payingenoughattention.pdf
2.
Association of London Government. (ALG). ( 2003). Education panel, special education needs. Downloaded January, 10, 2006, from www.alg.gov.uk
3.
American Academy of Child and Adolescent Psychiatry. (1997). Practice parameters for the assessment and treatment of children, adolescents, and adults with attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 85S-121S.
British Psychological Society. (BPS). (2000 ). Attention deficit/hyperactivity disorder: Guidelines and principles for successful multi-agency working. Leicester : Author.
6.
Burgess, I.C. (2002). Service innovations: Attention-deficit hyperactivity disorder - development of a multi-professional integrated care pathway. Psychiatric Bulletin, 26, 148-151.
7.
Coghill, D. (2006). Making the most of scant resources. ACPP Occasional Papers. London: ACAMH.
8.
Department of Health. (DoH). (2004). National service framework for children, young people and maternity services . Child and Adolescent Mental Health (CAMHS). London: Author.
9.
Ford,T., Goodman, R., & Meltzer, H. (2003). The British Child and Adolescent Mental Health Survey 1999: The prevalence of DSM-IV disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42(10), 1203-1211.
10.
Hill, P., & Cameron, M. (1999). Recognising hyperactivity: A guide for the cautious clinician. Child and Adolescent Mental Health, 4, 50-60.
11.
Hill, P., & Taylor, E. (2001). An auditable protocol for treating attention deficit/hyperactivity disorder. Archives of Disease in Childhood, 84, 404-409.
12.
Kendall, J. (1999). Sibling accounts of attention deficit hyperactivity disorder (ADHD). Family Process, 38, 117-136.
13.
National Institute for Health and Clinical Excellence. (NICE). (2000). Guidance on the use of methylphenidate (Ritalin, Equasym) for attention-deficit/hyperactivity disorder (ADHD) in childhood. London: Author.
14.
National Institute for Health and Clinical Excellence. (NICE). (2006). Methyphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents . Review of Technology Appraisal13; Technology Appraisal98, March 2006.
15.
Parr, J.R., Ward, A., & Inman, S. (2003). Current practice in the management of attention deficit with hyperactivity (ADHD). Child: Care, Health and Development, 29, 215-218.
16.
Podolski, C.L., & Nigg, J.T. (2001). Parent stress and coping in relation to child ADHD severity and associated child disruptive behavior problems. Journal of Clinical Child Psychology, 30, 503-513.
17.
Prasad, S., & Poole L., on behalf of the SUNBEAM Study Group. (2006). Assessing quality of life in children and adolescents with ADHD: SUNBEAM, an open comparative study of atomoxetine and standard therapy. Patient Reported Outcomes Newsletter, 36, 16-19.
18.
Prasad, S., Harpin, V., Poole, L., Zeitlin, H., Jamdar, S., & Puvanendran, K.on behalf of the SUNBEAM Study Group (2007) . A multicentre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD) Current Medical Research and Opinion, 23, 379-394.
19.
Ralston, S.J., Lorenzo, M.J.M., & the ADORE Study Group ( 2004). ADORE: Attention-Deficit Hyperactivity Disorder Observational Research in Europe. European Child and Adolescent Psychiatry , 13, 136-142.
20.
Rushton, J.L., Fant, K.E., & Clark, S.J. (2004). Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics, 114, 23-28.
21.
Salmon, G., & Kemp, A. (2002). ADHD: A survey of psychiatric and paediatric practice . Child and Adolescent Mental Health, 7, 73.
22.
Sayal, K., Taylor, E., Beecham, J., & Byrne, P. (2002). Pathways to care in children at risk of attention-deficit hyperactivity disorder. British Journal of Psychiatry, 181, 43-48.
23.
Scottish Intercollegiate Guidelines Network. (SIGN). (2001). Attention deficit and hyperkinetic disorders in children and young people: A national clinical guideline. Edinburgh: Author.
24.
Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski,T., Buitelaar, J., et al. (2004). European clinical guidelines for hyperkinetic disorder: First upgrade. European Child and Adolescent Psychiatry , 13(Suppl 1),17-30.
25.
Taylor, E., Sergeant, J., Doepfner, M., Gunning, B., Overmeyer, S., Mobius, H.J., & Eisert, H.G. (1998). Clinical guidelines for hyperkinetic disorder . European Child and Adolescent Psychiatry, 7, 184-200.
26.
Thapar, A., & Thapar, A. (2002). Is primary care ready to take on attention deficit hyperactivity disorder? BMC Family Practice, 3, 7.
27.
Thompson, M.J.J., Coll, X., Wilkinson, S., Uitenbroek, D., & Tobias, A. (2003). Evaluation of a mental health service for young children: development, outcome and satisfaction. Child and Adolescent Mental Health, 8, 68-77.
28.
Timimi, S., & Taylor, E. (2004). ADHD is best understood as a cultural construct . British Journal of Psychiatry, 184, 8-9.
